ONESOURCE1,548.10

Onesource Specialty Pharma Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersSTARDIVISLABGLANDPFIZERPOLYMEDRAINBOWKIMSJUBLPHARMAMcap ₹17,744 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,444.91,421.61,543.3
Other Income17.515.013.6
Total Income1,462.31,436.61,556.9
Expenses
+ Cost of Materials Consumed328.2436.8497.0
+ Purchases of Stock-in-Trade30.10.00.0
+ Changes in Inventories76.77.9-0.5
+ Employee Benefit Expense215.3242.3258.4
+ Finance Costs166.3122.2125.5
+ Depreciation & Amortisation273.9279.1283.0
+ Other Expenses328.0430.5449.4
Total Expenses1,418.51,518.61,612.8
EBITDA466.5304.2339.1
EBIT192.625.156.0
Profit
PBT before Exceptional Items43.8-82.0-55.9
+ Exceptional Items-110.8-9.9-11.4
Pretax Income-67.1-92.0-67.3
+ Current Tax11.82.22.3
+ Deferred Tax-61.6-20.4-20.9
Tax Expense-49.8-18.2-18.6
Net Income-18.0-73.8-48.6
+ Net Income — Continuing Ops-17.3-73.8-48.6
+ Net Income — Discontinued Ops-0.70.00.0
+ Other Comprehensive Income-3.216.116.6
Total Comprehensive Income-21.1-57.7-32.0
Net Income to Common-73.8
Per Share
Basic EPS-1.63-6.44-4.24
Diluted EPS-1.63-6.44-4.25
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax-0.70.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income-3.216.116.6
+ Items NOT to be Reclassified to P&L-6.70.4
+ Tax on Items NOT to be Reclassified3.20.00.0
+ Items to be Reclassified to P&L22.7
Comprehensive Income — Owners of Parent16.1
Per Share — as-filed variants
Basic EPS — Continuing Operations-1.63-6.44-4.24
Diluted EPS — Continuing Operations-1.63-6.44-4.25
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,009.8976.91,046.9
Gross Margin %69.8968.7267.83
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)43.8-82.0-55.9
− Exceptional Items (reconciliation)-110.8-9.9-11.4
Net Income Adj (tax-effected)26.4-65.8-40.4
EPS Adj2.39-5.74-3.52
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.00
Filed Debt Equity0.00
Filed Dscr0.01
Filed Iscr0.02
Paid Up Equity Capital11.411.511.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.